#USA #New York #Clinical Trials #Healthcare Innovations #Health Press Release

Weekly Highlights: 14 Must-See Health Press Releases Recap

In a week brimming with impactful news from the healthcare sector, we've compiled a list of 14 press releases that are essential reading for anyone interested in recent developments. From promising clinical trials to initiatives that aim to improve mental health support, here's a summary of the most significant stories that captured attention.

Key Highlights

1. Neurostimulation Device Reduces Opioid Use

A recent study published in Frontiers in Psychiatry found that the NET Recovery's FDA-cleared neurostimulation device, known as the NET Device™, could significantly reduce opioid and stimulant use among patients. The study revealed patients who used the device for at least 24 hours during opioid withdrawal experienced fewer days of substance use over the three months following residential treatment. This breakthrough offers new hope amid the ongoing addiction crisis.

2. Alsana Expands Virtual Eating Disorder Treatment

Alsana announced plans to expand its virtual treatment for eating disorders to over 30 states, enhancing accessibility to comprehensive care. Their program combines medical, therapeutic, and nutritional support via secure telehealth platforms, particularly benefiting individuals transitioning from residential to home care.

3. AFSP Launches 'The Upright' Series

The American Foundation for Suicide Prevention (AFSP) launched The Upright, a three-part virtual series aimed at promoting health equity in suicide prevention. The initiative provides valuable resources and fosters collaboration among experts, addressing the disproportionate impact of suicide in specific communities.

4. GammaTile Trial Shows Promising Results

A groundbreaking clinical trial confirmed that the GammaTile technology delivers superior tumor control compared to standard treatments for patients with newly diagnosed operable brain metastases. The researchers noted a remarkable reduction in tumor recurrence risk, making this approach a potential game-changer in oncology.

5. Thinx Empowers Teen Athletes

Thinx takes a stand by distributing free period products to girls' sports teams, recognizing that 93% of teens report having negative experiences in sports due to menstruation. This initiative aims to keep young athletes comfortable and confident, ensuring they can focus on their performance.

6. Celebrating Two Decades of Sam's Night Event

Parent Project Muscular Dystrophy marked its 20th anniversary of the Sam's Night event, celebrating significant community impact. Over the years, the event has raised more than $10 million to advance research and improve care standards for families affected by Duchenne muscular dystrophy.

7. Expansion of Medical Cannabis Access

The American Council of Cannabis Medicine introduced a new initiative to broaden access to medical cannabis. By partnering with top insurance providers, they are ensuring comprehensive coverage for both policyholders and companies, marking a significant step towards increased acceptance and use of medical cannabis.

8. VERA-MH: A New Open-Source Tool

Spring Health and its Expert Council launched VERA-MH, the first open-source tool for validating AI in mental health applications. This transparent evaluation framework establishes a standard for assessing the safety and efficacy of chatbots and large language models designed for psychological support.

9. VK2735 Clinical Trial Initiated by Viking Therapeutics

Viking Therapeutics announced the start of a clinical trial for VK2735, focusing on patients with obesity. The trial intends to evaluate various dosing regimens to maintain weight loss achieved through their weekly subcutaneous treatments.

10. Novo Nordisk's Semaglutide Gains FDA Approval

Novo Nordisk's oral semaglutide has received FDA approval for reducing cardiovascular risks in high-risk adults with type 2 diabetes, reinforcing the company's commitment to improving chronic disease management.

11. Boston Scientific to Acquire Nalu Medical

Boston Scientific revealed its plans to acquire Nalu Medical for approximately $533 million, further expanding its portfolio in medical technology and innovation.

12. Leading Fetal Neonatal Surgeon Joins NYU Langone Health

NYU Langone Health welcomed Dr. Peiro as the new director of its Advanced Fetal Care Center. Dr. Peiro's extensive expertise in fetal surgeries is expected to enhance the hospital's capabilities.

13. ACG Invests in U.S. Capsule Manufacturing

ACG announced a $200 million investment in hard-shell capsule manufacturing facilities in Atlanta, Georgia. This initiative not only signifies growth in production capabilities but also promises job creation.

14. March of Dimes Celebrates Maternal Health

The March of Dimes brought together influential voices, including notable personalities, to share inspiring stories about motherhood and resilience, advocating for improved maternal and infant health.

These stories reflect the latest advancements and initiatives aimed at improving health outcomes across various sectors. Stay tuned for more updates and insights from the healthcare landscape in the weeks to come. For journalists looking for relevant press releases, consider joining PR Newswire to customize your news feed and stay informed about industry updates.